Teladoc Health (TDOC)
(Delayed Data from NYSE)
$9.04 USD
+0.36 (4.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $9.07 +0.03 (0.33%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.04 USD
+0.36 (4.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $9.07 +0.03 (0.33%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Zacks News
Will High Tech Costs Hurt Teladoc Health (TDOC) in Q2 Earnings?
by Zacks Equity Research
Teladoc Health's (TDOC) Q2 results are likely to have benefited from improved access fees and growing BetterHelp membership, partly offset by elevated technology and development expenses.
Teladoc (TDOC) & Microsoft Partner to Reduce Administrative Woes
by Zacks Equity Research
Teladoc (TDOC) collaborates with Microsoft, enabling automatic clinical documentation with the help of AI.
Icon PLC (ICLR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $25.35, moving +1.56% from the previous trading session.
Teladoc (TDOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $24.55 in the latest trading session, marking a -0.73% move from the prior day.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $22.57 in the latest trading session, marking a +0.04% move from the prior day.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $25.25, marking a -0.16% move from the previous day.
Teladoc (TDOC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $24.48, marking a -1.61% move from the previous day.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $24.91 in the latest trading session, marking a -1.7% move from the prior day.
Why Is Viatris (VTRS) Down 2.4% Since Last Earnings Report?
by Zacks Equity Research
Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $24.79, marking a +1.27% move from the previous day.
Why Is Teladoc (TDOC) Down 16.5% Since Last Earnings Report?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Hold on to Teladoc Health (TDOC) Stock for Now?
by Zacks Equity Research
Teladoc Health's (TDOC) cash-generating abilities are boosted by the growing number of visits and memberships.
Teladoc Health (TDOC) Shares Up 5% Since Q1 Earnings Release
by Zacks Equity Research
Teladoc Health's (TDOC) Q1 results reflect solid chronic care product revenues and improving access fees and other revenues.
3 Steps to Indentifying the Market Environment
by Andrew Rocco
In order to be profitable, investors must know what type of environment they are in. Currently, quality growth stocks are driving the market higher.
Teladoc (TDOC) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Teladoc (TDOC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Teladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 27.45% and 1.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Can Rising Expenses Hurt Teladoc Health's (TDOC) Q1 Earnings?
by Zacks Equity Research
Teladoc Health's (TDOC) first-quarter results are likely to reflect growth in Access Fees revenues and total visits.
Analysts Estimate Pediatrix Medical Group (MD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Pediatrix Medical Group (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in Teladoc (TDOC): Can Its 5.7% Jump Turn into More Strength?
by Zacks Equity Research
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $25.87, marking a +1.09% move from the previous day.
Here's Why You Should Hold Teladoc Health (TDOC) Stock Now
by Zacks Equity Research
Teladoc Health (TDOC) remains well-poised for growth on the back of solid revenues, sustained demand for virtual care services and sufficient cash-generating abilities.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $25.61, marking a -1.12% move from the previous day.